1. Home
  2. OP vs TTNP Comparison

OP vs TTNP Comparison

Compare OP & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OP
  • TTNP
  • Stock Information
  • Founded
  • OP 2021
  • TTNP 1991
  • Country
  • OP Greece
  • TTNP United States
  • Employees
  • OP N/A
  • TTNP N/A
  • Industry
  • OP
  • TTNP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OP
  • TTNP Health Care
  • Exchange
  • OP Nasdaq
  • TTNP Nasdaq
  • Market Cap
  • OP 5.3M
  • TTNP 5.9M
  • IPO Year
  • OP N/A
  • TTNP 1996
  • Fundamental
  • Price
  • OP $1.59
  • TTNP $4.35
  • Analyst Decision
  • OP
  • TTNP
  • Analyst Count
  • OP 0
  • TTNP 0
  • Target Price
  • OP N/A
  • TTNP N/A
  • AVG Volume (30 Days)
  • OP 9.3M
  • TTNP 23.0K
  • Earning Date
  • OP 08-06-2025
  • TTNP 08-14-2025
  • Dividend Yield
  • OP N/A
  • TTNP N/A
  • EPS Growth
  • OP N/A
  • TTNP N/A
  • EPS
  • OP N/A
  • TTNP N/A
  • Revenue
  • OP $25,702,000.00
  • TTNP N/A
  • Revenue This Year
  • OP N/A
  • TTNP N/A
  • Revenue Next Year
  • OP N/A
  • TTNP N/A
  • P/E Ratio
  • OP N/A
  • TTNP N/A
  • Revenue Growth
  • OP 35.58
  • TTNP N/A
  • 52 Week Low
  • OP $0.63
  • TTNP $3.03
  • 52 Week High
  • OP $3.17
  • TTNP $14.80
  • Technical
  • Relative Strength Index (RSI)
  • OP 51.70
  • TTNP 47.86
  • Support Level
  • OP $1.82
  • TTNP $4.17
  • Resistance Level
  • OP $2.30
  • TTNP $4.65
  • Average True Range (ATR)
  • OP 0.52
  • TTNP 0.21
  • MACD
  • OP -0.04
  • TTNP -0.03
  • Stochastic Oscillator
  • OP 36.55
  • TTNP 33.96

About OP OceanPal Inc.

OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.

About TTNP Titan Pharmaceuticals Inc.

Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.

Share on Social Networks: